Nkarta (NKTX) Change in Acquisitions & Divestments (2020 - 2026)

Nkarta's (NKTX) quarterly Change in Acquisitions & Divestments came in at $70.6 million in Q1 2026, down 6.4% year-on-year from $75.4 million in Q1 2025, and down 24.15% quarter-over-quarter from $93.1 million in Q4 2025.

Nkarta (NKTX) Change in Acquisitions & Divestments (2020 - 2026) Analysis & Trends

Nkarta's Change in Acquisitions & Divestments history runs 7 years deep, the most recent figure standing at $70.6 million for Q1 2026.

  • On a quarterly basis, Change in Acquisitions & Divestments fell 6.4% year-over-year to $70.6 million in Q1 2026; TTM through Mar 2026 was $335.3 million, a 13.66% increase from a year earlier, with the FY2025 full-year figure at $340.1 million, up 20.93% from the prior year.
  • Change in Acquisitions & Divestments slipped to $70.6 million in Q1 2026 per NKTX's latest filing, from $93.1 million in the prior quarter.
  • Across five years, Change in Acquisitions & Divestments topped out at $126.0 million in Q1 2023 and bottomed at $29.2 million in Q1 2022.
  • The 5-year median for Change in Acquisitions & Divestments is $75.4 million (2025), against an average of $76.9 million.
  • Across the five-year window, Change in Acquisitions & Divestments sank 53.69% in 2022 and surged 331.41% in 2023, its largest moves.
  • Year by year, Change in Acquisitions & Divestments stood at $115.4 million in 2022, then slipped by 25.45% to $86.0 million in 2023, then retreated by 4.3% to $82.3 million in 2024, then climbed by 13.1% to $93.1 million in 2025, then slipped by 24.15% to $70.6 million in 2026.
  • Per Business Quant, the three latest NKTX Change in Acquisitions & Divestments figures stand at $70.6 million (Q1 2026), $93.1 million (Q4 2025), and $83.2 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 66,981.90 Bn 66,981.62 Bn -
2 Nanobiotix 1,924.26 Bn 1,924.20 Bn -
3 Akari Therapeutics 975.59 Bn 975.59 Bn -
4 BeOne Medicines 472.11 Bn 467.32 Bn 1.35 Bn
5 Vertex Pharmaceuticals 121.89 Bn 114.65 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 69.93 Bn 61.18 Bn 3.31 Bn
7 Belite Bio 62.83 Bn 62.83 Bn -
8 Argenx Se 55.82 Bn 50.63 Bn 1.41 Bn
9 Revolution Medicines 37.49 Bn 37.49 Bn -
10 Nkarta 170.42 Mn 170.42 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 70.61 Mn
Mar 31, 2026 70.61 Mn
Dec 31, 2025 93.08 Mn
Dec 31, 2025 93.08 Mn
Sep 30, 2025 83.16 Mn
Sep 30, 2025 83.16 Mn
Jun 30, 2025 88.42 Mn
Jun 30, 2025 88.42 Mn
Mar 31, 2025 75.44 Mn
Mar 31, 2025 75.44 Mn
Dec 31, 2024 82.30 Mn
Dec 31, 2024 82.30 Mn
Sep 30, 2024 68.23 Mn
Sep 30, 2024 68.23 Mn
Jun 30, 2024 69.00 Mn
Jun 30, 2024 69.00 Mn
Mar 31, 2024 61.70 Mn
Mar 31, 2024 61.70 Mn
Dec 31, 2023 86.00 Mn
Dec 31, 2023 86.00 Mn